Nika Pharmaceuticals Inc Statistics
Nika Pharmaceuticals Inc (NIKA) Stock Statistics & Valuation Metrics
Total Valuation
Nika Pharmaceuticals Inc has a market cap or net worth of $368.09M. The enterprise value is $534.55T.
- Market Cap
- $368.09M
- Enterprise Value
- $534.55T
Share Statistics
Nika Pharmaceuticals Inc has 1,054,689,200 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 1,054,689,200
- Owned by Insiders
- ―
- Owned by Institutions
- ―
Financial Efficiency
Nika Pharmaceuticals Inc’s return on equity (ROE) is 0.26 and return on invested capital (ROIC) is 25.67%.
- Return on Equity (ROE)
- 0.26
- Return on Assets (ROA)
- -3.64
- Return on Invested Capital (ROIC)
- 25.67%
- Return on Capital Employed (ROCE)
- 0.26
- Revenue Per Employee
- ―
- Profits Per Employee
- ―
- Employee Count
- 0
- Asset Turnover
- 0.00
- Inventory Turnover
- 0.00
Valuation Ratios
The current PE Ratio of Nika Pharmaceuticals Inc is -4439.51. Nika Pharmaceuticals Inc’s PEG ratio is 44.40.
- PE Ratio
- -4439.51
- PS Ratio
- 0.00
- PB Ratio
- -1074.01
- Price to FCF
- -5200.13
- Price to Operating Cash Flow
- -5214.96
- PEG Ratio
- 44.40
Income Statement
In the last 12 months, Nika Pharmaceuticals Inc had revenue of 0 and earned -76.40K in profits. Earnings per share was -0.00.
- Revenue
- 0
- Gross Profit
- 0
- Operating Income
- -76.40K
- Pretax Income
- -76.40K
- Net Income
- -76.40K
- EBITDA
- -76.40K
- Earnings Per Share (EPS)
- -0.00
Cash Flow
In the last 12 months, operating cash flow was -70.78K and capital expenditures 0, giving a free cash flow of -70.78K billion.
- Operating Cash Flow
- -70.78K
- Free Cash Flow
- -70.78K
- Free Cash Flow per Share
- -0.00
Dividends & Yields
Nika Pharmaceuticals Inc pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -0.02%
- Earnings Yield
- -0.02%
Stock Price Statistics
- Beta
- 0.42
- 52-Week Price Change
- 16.67%
- 50-Day Moving Average
- 0.39
- 200-Day Moving Average
- 0.51
- Relative Strength Index (RSI)
- 8.01
- Average Volume (3m)
- 1,884
Financial Position
Nika Pharmaceuticals Inc as a current ratio of 0.07, with Debt / Equity ratio of 0.00%
- Current Ratio
- 0.07
- Quick Ratio
- 0.07
- Debt to Market Cap
- 0.00
- Net Debt to EBITDA
- 0.02
- Interest Coverage Ratio
- 0.00
Taxes
In the past 12 months, Nika Pharmaceuticals Inc has paid 0 in taxes.
- Income Tax
- 0
- Effective Tax Rate
- 0.00
Enterprise Valuation
Nika Pharmaceuticals Inc EV to EBITDA ratio is -4426.88, with an EV/FCF ratio of -5200.13.
- EV to Sales
- 0.00
- EV to EBITDA
- -4426.88
- EV to Free Cash Flow
- -5200.13
- EV to Operating Cash Flow
- -5200.13
Balance Sheet
Nika Pharmaceuticals Inc has $352.00 in cash and marketable securities with $0.00 in debt, giving a net cash position of $352.00 billion.
- Cash & Marketable Securities
- $352.00
- Total Debt
- $0.00
- Net Cash
- $352.00
- Net Cash Per Share
- $0.00
- Tangible Book Value Per Share
- $0.00
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
- Gross Margin
- 0.00%
- Operating Margin
- 0.00%
- Pretax Margin
- 0.00%
- Net Profit Margin
- 0.00%
- EBITDA Margin
- 0.00%
- EBIT Margin
- 0.00%
Analyst Forecast
The average price target for Nika Pharmaceuticals Inc is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- 0
- Revenue Growth Forecast
- ―
- EPS Growth Forecast
- ―

